re7338051
/portal/mircera
MIRCERA.com
skip to the content
Home
Introduction to MIRCERA
Features and Benefits
Mode of action
Once-monthly efficacy
Comparable safety
Successful direct conversion
What is MIRCERA
Mode of action
Pharmacokinetics & pharmacodynamics
Mode of action video
How is MIRCERA supplied
Using MIRCERA
Correction
Conversion
Maintenance
Dosing & Administration
Erythropoiesis-stimulating agent-naïve patients
Patients converting to MIRCERA
Dose adjustment
Special populations
Safety
Value and convenience
Clinical Study Highlights
Correction studies
Correction Phase II
Correction Phase III
Maintenance studies
Maintenance Phase II
Maintenance Phase III (MAXIMA, PROTOS, STRIATA and RUBRA)
Resources
WCN 2009 Videos
Dr Adrian Covic
(WCN 2009)
Dr Donal O'Donoghue
(WCN 2009)
Dr Danilo Fliser
(WCN 2009)
Prescribing information
Publications
Congress and events calendar
Renal Academy 2008 videos
Dr Tony Besarab
(Renal Academy 2008)
Dr Helio Tedesco Silva
(Renal Academy 2008)
ASN 2008 Videos
Dr Danilo Fliser
(ASN 2008)
Dr Robert Provenzano
(ASN 2008)
EDTA Poster Videos
www.anaemiaworld.com